The sGC stimulator riociguat inhibits platelet function in washed platelets but not in whole blood

BACKGROUND AND PURPOSE: Stimulation of soluble guanylyl cyclase (sGC) is a valuable therapeutic strategy for the treatment of several cardiovascular diseases. The sGC stimulator riociguat has been approved for the treatment of two forms of pulmonary hypertension. Platelets contain large amounts of s...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Br J Pharmacol
Main Authors: Reiss, C., Mindukshev, I., Bischoff, V., Subramanian, H., Kehrer, L., Friebe, A., Stasch, J.‐P., Gambaryan, S., Walter, U.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2015
Teme:
Research Papers
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4687809/
https://ncbi.nlm.nih.gov/pubmed/26282717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13286
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki